FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Feb 9, 2022
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on February 9, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood, Inc.
- Inspection Date
- February 9, 2022
- Product Type
- Biologics
View Company Profile
ID · 7257e527-59f0-46f9-943f-0866b45088a4
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1162423
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2024 | Not classified | Florida District Office | |
| February 26, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 14, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 11, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1250131 - 2024-09-24
- FDA Inspection 1081205 - 2019-02-26
- FDA Inspection 997062 - 2016-12-14
- FDA Inspection 913508 - 2015-02-11
- FDA Inspection 827219 - 2013-04-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.